Company profile for CDR Life

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The CDR-Life team covers all areas of expertise in biologics drug development from discovery to technical development and has experience through all phases of development – from early phase to Biologics licensing application (BLA) submission. Our discovery team holds deep antibody engineering know-how. The team identifies the first target hits and use their outstanding know-how to compose multi-specific therapeutic antibodie...
The CDR-Life team covers all areas of expertise in biologics drug development from discovery to technical development and has experience through all phases of development – from early phase to Biologics licensing application (BLA) submission. Our discovery team holds deep antibody engineering know-how. The team identifies the first target hits and use their outstanding know-how to compose multi-specific therapeutic antibodies with drug-like properties suitable for development. Our pharmacology team has strong expertise within oncology, immunology, and ophthalmology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Wagistrasse 27 8952 Schlieren Zurichsw
Telephone
Telephone
+41 44 515 98 98
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251104115074/en/Boehringer-Ingelheim-and-CDR-Life-Expand-Collaboration-Efforts-with-Global-Licensing-Agreement-for-CDR111-an-Antibody-Based-Trispecific-M-gager-for-Autoimmune-Diseases

BUSINESSWIRE
04 Nov 2025

https://www.businesswire.com/news/home/20251023009760/en/CDR-Life-Presents-Early-Clinical-Data-Demonstrating-Pharmacodynamic-Activity-of-CDR404-a-Novel-Antibody-Derived-T-Cell-Engager-Targeting-MAGE-A4-Solid-Tumors

BUSINESSWIRE
23 Oct 2025

https://www.businesswire.com/news/home/20250626881539/en/CDR-Life-Announces-CDR609-as-New-T-Cell-Engager-Clinical-Candidate-Targeting-LGR5-a-Highly-Cancer-specific-Surface-Antigen-Widely-Expressed-on-Common-Solid-Tumor

BUSINESSWIRE
26 Jun 2025

https://www.businesswire.com/news/home/20241205298892/en

BUSINESSWIRE
05 Dec 2024

https://www.businesswire.com/news/home/20240913900454/en

BUSINESSWIRE
13 Sep 2024

https://www.globenewswire.com/news-release/2022/08/23/2502755/0/en/CDR-Life-Announces-Appointment-of-Swethajit-Biswas-MD-as-Chief-Medical-Officer.html

GLOBENEWSWIRE
23 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty